REG - Nuformix PLC - Director/PDMR Dealings

NuformixAnnouncement

05/11/2024 14:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241105:nRSE0442La&default-theme=true

RNS Number : 0442L  Nuformix PLC  05 November 2024

5 November 2024

 

Nuformix plc

 

("Nuformix" or the "Company" or the "Group")

 

Director/PDMR Dealings

 

Nuformix plc (LSE:NFX), a pharmaceutical development company targeting unmet
medical needs in fibrosis and oncology via drug repurposing, announces further
to the completion of the Placing and Subscription to raise gross proceeds of
£300,000, as announced on 20 September 2024, and Admission of the New
Ordinary Shares today, further details of the Directors' participation in the
Fundarise.

 

Each of the Company's Directors have subscribed for the following New Ordinary
Shares at the Issue Price:

 

 Name            Position                Ordinary shares subscribed for  % held of enlarged share capital on Admission
 Julian Gilbert  Non-Executive Chairman  22,000,000                      1.57%
 Maddy Kennedy   Non-Executive Director  22,000,000                      1.57%
 Dan Gooding     Executive Director      12,000,000                      3.49%

 

The notifications below, made in accordance with the requirements of the EU
Market Abuse Regulation (2014/596/EU) as it forms part of United Kingdom
domestic law by virtue of the European Union (Withdrawal) Act 2018 and as
modified by or under the European Union (Withdrawal) Act 2018 or other
domestic law, provides further detail.

 

Terms used in this announcement shall, unless the context otherwise requires,
be as defined in the Prospectus published by the Company on 16 October 2024.

 

Enquiries:

 

 Nuformix plc
 Dr Dan Gooding, Executive Director  Via IFC Advisory

 CMC Markets
 Douglas Crippen                     +44 (0) 20 3003 8632

 IFC Advisory Limited
 Tim Metcalfe                        +44 (0) 20 3934 6630

 Zach Cohen                          nuformix@investor-focus.co.uk

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Julian Gilbert
 2   Reason for the notification
 a)  Position/status                                              Non-Executive Chairman
 b)  Initial notification/ Amendment                              Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Nuformix plc
 b)  LEI                                                          2138003XG3H3I2J3BJ24
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of nominal value 0.05 pence

     Identification code

                                                                  GB00BYW79Y38
 b)  Nature of the transaction                                    Purchase of ordinary shares
 c)  Price(s) and volume(s)

                                                                  Price(s) Volume(s)

                                                                  0.05 pence

                                                                  22,000,000
 d)  Aggregated information

     - Aggregated volume                                          22,000,000

     - Price                                                      £11,000
 e)  Date of the transaction                                      5 November 2024
 f)  Place of the transaction                                     Outside a trading venue

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Maddy Kennedy
 2   Reason for the notification
 a)  Position/status                                              Non-Executive Director
 b)  Initial notification/ Amendment                              Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Nuformix plc
 b)  LEI                                                          2138003XG3H3I2J3BJ24
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of nominal value 0.05 pence

     Identification code

                                                                  GB00BYW79Y38
 b)  Nature of the transaction                                    Purchase of ordinary shares
 c)  Price(s) and volume(s)

                                                                  Price(s) Volume(s)

                                                                  0.05 pence

                                                                  22,000,000
 d)  Aggregated information

     - Aggregated volume                                          22,000,000

     - Price                                                      £11,000
 e)  Date of the transaction                                      5 November 2024
 f)  Place of the transaction                                     Outside a trading venue

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Dan Gooding
 2   Reason for the notification
 a)  Position/status                                              Executive Director
 b)  Initial notification/ Amendment                              Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Nuformix plc
 b)  LEI                                                          2138003XG3H3I2J3BJ24
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of nominal value 0.05 pence

     Identification code

                                                                  GB00BYW79Y38
 b)  Nature of the transaction                                    Purchase of ordinary shares
 c)  Price(s) and volume(s)

                                                                  Price(s) Volume(s)

                                                                  0.05 pence

                                                                  12,000,000
 d)  Aggregated information

     - Aggregated volume                                          12,000,000

     - Price                                                      £6,000
 e)  Date of the transaction                                      5 November 2024
 f)  Place of the transaction                                     Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFFSLSLEIIS